SARS-CoV-IN-2

• CAT Number: I016219
• CAS Number: 888958-26-7
• Molecular Formula: C₂₄H₁₈ClFeN₃O
• Molecular Weight: 455.72
• Purity: ≥95%
• Target: SARS-CoV

SARS-CoV-IN-2（Cat No.:I016219）is a small molecule inhibitor targeting the main protease (Mpro) of the SARS-CoV-2 virus. By inhibiting Mpro, which plays a crucial role in viral replication and maturation, SARS-CoV-IN-2 impedes the viral life cycle, reducing viral load and potentially alleviating COVID-19 symptoms. This compound is being explored as part of ongoing antiviral drug development to combat SARS-CoV-2 infections. Its specificity for Mpro makes it a promising candidate in the search for effective treatments against COVID-19 and other coronaviruses.

Reference

[1]. Biot C, et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49(9):2845-9.